At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
02877 SHINEWAY PHARM
Not Yet Opened 02-14 16:08:41
8.280
+0.130
+1.60%
High8.290Low8.130Vol1.02M
Open8.290D1 Closing8.150Amplitude1.96%
Mkt Cap6.85BTradable Cap6.85BTotal Shares827.00M
T/O8.38MT/O Rate0.12%Tradable Shares827.00M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--
Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.
UOB Kay Hian Downgrades China Shineway Pharmaceutical Group to Hold from Buy; Price Target is HK$8.50
MT Newswires Live  ·  01-27
UOB Kay Hian Downgrades China Shineway Pharmaceutical Group to Hold from Buy; Price Target is HK$8.50
Here's Why We Think China Shineway Pharmaceutical Group (HKG:2877) Is Well Worth Watching
Simply Wall St.  ·  2024-12-19
Here's Why We Think China Shineway Pharmaceutical Group (HKG:2877) Is Well Worth Watching
BRIEF-China Shineway Pharmaceutical Posts Nine Months Turnover RMB2,887 Mln
Reuters  ·  2024-11-08
BRIEF-China Shineway Pharmaceutical Posts Nine Months Turnover RMB2,887 Mln
China Shineway Pharmaceutical Logs 17% Decline in Q1-Q3 Turnover
MT Newswires Live  ·  2024-11-08
China Shineway Pharmaceutical Logs 17% Decline in Q1-Q3 Turnover
China Shineway Pharmaceutical - Nine Months Turnover RMB 2,887 Mln Down 16.9%
THOMSON REUTERS  ·  2024-11-08
China Shineway Pharmaceutical - Nine Months Turnover RMB 2,887 Mln Down 16.9%
China Shineway Pharmaceutical Group Limited's (HKG:2877) Price Is Right But Growth Is Lacking After Shares Rocket 27%
Simply Wall St.  ·  2024-10-19
China Shineway Pharmaceutical Group Limited's (HKG:2877) Price Is Right But Growth Is Lacking After Shares Rocket 27%
China Shineway Pharmaceutical Group's (HKG:2877) 12% CAGR outpaced the company's earnings growth over the same five-year period
Simply Wall St.  ·  2024-09-26
China Shineway Pharmaceutical Group's (HKG:2877) 12% CAGR outpaced the company's earnings growth over the same five-year period
Stock Track | Shineway Pharmaceutical Surges Nearly 9% on Higher First-Half Profit
Stock Track  ·  2024-08-29
Stock Track | Shineway Pharmaceutical Surges Nearly 9% on Higher First-Half Profit
China Shineway Pharmaceutical Posts About 28% Higher H1 Profit
MT Newswires Live  ·  2024-08-29
China Shineway Pharmaceutical Posts About 28% Higher H1 Profit
China Shineway Pharmaceutical - Hy Turnover Amounted to RMB2.09 Bln
THOMSON REUTERS  ·  2024-08-29
China Shineway Pharmaceutical - Hy Turnover Amounted to RMB2.09 Bln
China Shineway Pharmaceutical Group H1 Gross Margin 75.3%
THOMSON REUTERS  ·  2024-08-29
China Shineway Pharmaceutical Group H1 Gross Margin 75.3%

Introduction

Company Name.
SHINEWAY PHARM
Affiliated Markets:
SEHK
Listing Date:
--
Main Business:
China Shineway Pharmaceutical Group Limited is an investment holding company principally engaged in the research and development, manufacture and trading of modern Chinese medicines. Its main products include injections, soft capsules and granules. The Company’s subsidiaries include Yuan Da International Limited, Hong Zhan International Limited and Shineway Pharmaceutical Sales Company Limited.
Issue price:
--